Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-26 @ 2:10 AM
Study NCT ID:
NCT05970705
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2023-07-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-03
First Submit QC Date:
None
Study First Post Date:
2023-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-24
Last Update Post Date:
2023-08-01
Last Update Post Date Type:
ACTUAL